PAPER Van Thanh Nguyen N, Taverna M, Smadja C, Mai TD
SEARCH RESULTS
332 RESULTS
PAPER Meeker KL, Wisch JK, Hudson D, Coble D, Xiong C, Babulal GM, Gordon BA, Schindler SE, Cruchaga C, Flores S, Dincer A, Benzinger TL, Morris JC, Ances BM
Socioeconomic Status Mediates Racial Differences Seen Using the AT(N) Framework.
Ann Neurol. 2021 Feb;89(2):254-265. Epub 2020 Nov 7 PubMed: 33111990PAPER Ren J, Jiang F, Wang M, Hu H, Zhang B, Chen L, Dai F
Increased cross-linking micelle retention in the brain of Alzheimer's disease mice by elevated asparagine endopeptidase protease responsive aggregation.
Biomater Sci. 2020 Dec 7;8(23):6533-6544. Epub 2020 Oct 28 PubMed: 33111725PAPER Kanhed AM, Patel DV, Patel NR, Sinha A, Thakor PS, Patel KB, Prajapati NK, Patel KV, Yadav MR
Indoloquinoxaline derivatives as promising multi-functional anti-Alzheimer agents.
J Biomol Struct Dyn. 2020 Oct 28;:1-18. PubMed: 33111617PAPER Gao LJ, Li P, Ma T, Zhong ZQ, Xu SJ
Ligustilide alleviates neurotoxicity in SH-SY5Y cells induced by Aβ25-35 via regulating endoplasmic reticulum stress and autophagy.
Phytother Res. 2021 Mar;35(3):1572-1584. Epub 2020 Oct 27 PubMed: 33111362PAPER Gleason A, Bush AI
Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease.
Neurotherapeutics. 2020 Oct 27; PubMed: 33111259PAPER Vignaux PA, Minerali E, Foil DH, Puhl AC, Ekins S
Machine Learning for Discovery of GSK3β Inhibitors.
ACS Omega. 2020 Oct 20;5(41):26551-26561. Epub 2020 Oct 12 PubMed: 33110983PAPER Hestad K, Engedal K, Horndalsveen P, Strand BH
Blood Pressure in Different Dementia Disorders, Mild Cognitive Impairment, and Subjective Cognitive Decline.
Front Aging Neurosci. 2020;12:257. Epub 2020 Aug 31 PubMed: 33110409PAPER Bradley D
Clusterin as a Potential Biomarker of Obesity-Related Alzheimer's Disease Risk.
Biomark Insights. 2020;15:1177271920964108. Epub 2020 Oct 12 PubMed: 33110346PAPER Balasubramaniam M, Mainali N, Bowroju SK, Atluri P, Penthala NR, Ayyadevera S, Crooks PA, Shmookler Reis RJ
Structural modeling of GSK3β implicates the inactive (DFG-out) conformation as the target bound by TDZD analogs.
Sci Rep. 2020 Oct 27;10(1):18326. PubMed: 33110096PAPER Liew TM
Trajectories of subjective cognitive decline, and the risk of mild cognitive impairment and dementia.
Alzheimers Res Ther. 2020 Oct 27;12(1):135. PubMed: 33109275PAPER Wadhwa R, Paudel KR, Mehta M, Shukla SD, Sunkara K, Prasher P, Panth N, Goyal R, Chellappan DK, Gupta G, Hansbro PM, Aljabali AA, Tambuwala MM, Dua K
Beyond the Obvious: Smoking and Respiratory Infection Implications on Alzheimer's Disease.
CNS Neurol Disord Drug Targets. 2020;19(9):698-708. PubMed: 33109069PAPER Cummings J
Drug Development for Psychotropic, Cognitive-Enhancing, and Disease-Modifying Treatments for Alzheimer's Disease.
J Neuropsychiatry Clin Neurosci. 2021;33(1):3-13. Epub 2020 Oct 28 PubMed: 33108950PAPER Santangelo G, Raimo S, Erro R, Picillo M, Amboni M, Pellecchia MT, Pivonello C, Barone P, Vitale C
Vitamin D as a possible biomarker of mild cognitive impairment in parkinsonians.
Aging Ment Health. 2020 Oct 28;:1-5. PubMed: 33111573PAPER Kamalabadi YM, Sedigh SS, Abbaslou M
The relationship between DMFT index and cognitive impairment: A descriptive cross-sectional study.
J Family Med Prim Care. 2020 Aug;9(8):4317-4322. Epub 2020 Aug 25 PubMed: 33110852Current Filters
- Date Range : Oct 2020 to Oct 2020 x